Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMC

In vivo reprogramming of wound-resident cells generates skin epithelial tissue

Kurita M., Araoka T., Hishida T., O'Keefe DD., Takahashi Y., Sakamoto A.

Animal Study on Chronic Wound, published in Nature (2018) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Nature (2018)
Reported sample size
—
Source database
Europe PMC
PMID
30185909
PMCID
PMC9651909
DOI
10.1038/s41586-018-0477-4
Citations
109

Abstract (original English)

Large cutaneous ulcers are, in severe cases, life threatening 1,2 . As the global population ages, non-healing ulcers are becoming increasingly common 1,2 . Treatment currently requires the transplantation of pre-existing epithelial components, such as skin grafts, or therapy using cultured cells 2 . Here we develop alternative supplies of epidermal coverage for the treatment of these kinds of wounds. We generated expandable epithelial tissues using in vivo reprogramming of wound-resident mesenchymal cells. Transduction of four transcription factors that specify the skin-cell lineage enabled efficient and rapid de novo epithelialization from the surface of cutaneous ulcers in mice. Our findings may provide a new therapeutic avenue for treating skin wounds and could be extended to other disease situations in which tissue homeostasis and repair are impaired.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
FibroblastsEpithelial CellsKeratinocytesMesenchymal Stem CellsSkinAnimalsHumansMiceSkin UlcerWounds and Injuries

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research